Boston Scientific Corporation (BSX) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Marlborough, MA, United States. The current CEO is Michael F. Mahoney.
BSX has IPO date of 1992-05-19, 53,000 full-time employees, listed on the NYSE, a market capitalization of $94.85B.
Boston Scientific Corporation is a global medical device manufacturer that develops, manufactures, and markets innovative devices across interventional medical specialties. Operating through three primary segments—MedSurg, Rhythm and Neuro, and Cardiovascular—the company serves diverse therapeutic areas including gastrointestinal and pulmonary diagnostics, urology, cardiac rhythm management, neurostimulation, and interventional cardiology. Its comprehensive product portfolio encompasses implantable cardiac devices, ablation systems, coronary stents, peripheral vascular interventions, and oncology treatment solutions. Headquartered in Marlborough, Massachusetts, Boston Scientific has established itself as a leading provider of minimally invasive medical technologies that improve patient outcomes across multiple healthcare markets worldwide.
